adyn

adyn is a precision medicine company founded in 2019 and based in Claymont, Delaware, with early operations in Seattle, Washington.

The company focuses on leveraging personal genetic and hormonal data to provide actionable health insights, particularly for individuals transitioning from birth control to fertility. Their mission is to empower users to optimize their health while minimizing side effects associated with hormonal contraception. The flagship product, The Birth Control Optimization Test, is an at-home diagnostic kit that analyzes an individual's genetic profile and hormonal levels to recommend the most suitable birth control method. Users collect samples at home, and the test assesses hormone baselines and genetic risks for side effects like blood clots and depression. In addition to the test, adyn offers personalized reports, telemedicine consultations with licensed providers, and ongoing care to ensure users receive tailored support for their reproductive health needs. The company serves both individual consumers and healthcare providers, aiming to make precision medicine accessible to all.